PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNabriva Therapeutics
Nabriva Therapeutics(NBRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XenletaLefamulin2020-07-272028-2031
Community-acquired infections
,
Bacterial pneumonia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lefamulin
healthy volunteers/patients
,
fibrosis
,
cystic fibrosis
,
infections
,
bacterial infections
,
mycoplasma infections
,
pleuropneumonia
,
mycoplasma genitalium
,
pneumonia
,
community-acquired pneumonia
Bevifimod
head and neck neoplasms
,
stroke
,
atherosclerosis
,
intracranial arteriosclerosis
,
fallopian tube neoplasms
,
neoplasms
,
squamous cell carcinoma of head and neck
,
adenocarcinoma
,
prostatic neoplasms
,
renal cell carcinoma
,
triple negative breast neoplasms
,
basal cell carcinoma
,
neoplasm metastasis
,
basal cell neoplasms
,
ovarian epithelial carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
hypersensitivity
,
peanut hypersensitivity
,
allergic rhinitis
,
rhinitis
,
chronic disease
,
healthy volunteers/patients
,
squamous cell carcinoma
,
merkel cell carcinoma
,
lung diseases
,
adenocarcinoma of lung
,
food hypersensitivity
,
milk hypersensitivity
,
smoldering multiple myeloma
,
monoclonal gammopathy of undetermined significance
,
obesity
,
hearing loss
,
hearing disorders
,
sensorineural hearing loss
,
bronchogenic carcinoma
,
bronchial neoplasms
,
paroxysmal hemoglobinuria
,
colonic neoplasms
,
malignant mesothelioma
,
mesothelioma
,
chronic renal insufficiency
,
diabetic nephropathies
,
carcinoma
,
rectal neoplasms
,
non-alcoholic fatty liver disease
,
non-small-cell lung carcinoma
,
ovarian neoplasms
,
melanoma
,
lung neoplasms
,
retinal diseases
,
follicular lymphoma
,
diabetic retinopathy
,
hemorrhage
,
b-cell lymphoma
,
rheumatoid arthritis
,
ascites
,
recurrence
,
type 2 diabetes mellitus
,
multiple myeloma
,
heterotopic ossification
,
myositis ossificans
,
vitreous hemorrhage
,
hodgkin disease
,
large b-cell lymphoma diffuse
,
vision disorders
,
eye diseases
,
blindness
,
hyperlipidemias
,
diabetes mellitus
,
b-cell lymphoma marginal zone
,
non-hodgkin lymphoma
,
macular degeneration
,
protein-losing enteropathies
,
nasal polyps
,
asthma
,
macular edema
,
hemophilia b
Lactams
infections
,
radiotherapy
,
helicobacter infections
Trinessa
healthy volunteers/patients
Fluoroquinolone
healthy volunteers/patients
Isoxaflutole
therapeutic equivalency
,
healthy volunteers/patients
,
heart failure
,
cardiovascular diseases
,
heart diseases
,
cardiac arrhythmias
,
laparoscopy
,
growth
,
obesity
,
diet therapy
,
acute lung injury
,
lung injury
,
type 2 diabetes mellitus
,
body weight changes
,
atrial fibrillation
,
stroke
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use